Back to Search
ROBERT HADDAD, MD
MD
Medical Oncology Physician
NPI: 1942259098IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
209545(MA)
Education
OTHER
Class of 1995
Research & Publications (20)
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
PMID 19634161·Cancer·2009
3-trial
HPV16 transmission between a couple with HPV-related head and neck cancer.
PMID 18061523·Oral Oncol·2008
5-case
Multidisciplinary approach to cancer treatment: focus on head and neck cancer.
PMID 18154862·Dent Clin North Am·2008
6-review
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.
PMID 16785415·Arch Otolaryngol Head Neck Surg·2006
8-other
Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.
PMID 16601434·Am J Clin Oncol·2006
8-other
Current and future directions in the treatment of squamous cell carcinoma of the head and neck: multidisciplinary symposium on head and neck cancer.
PMID 16548781·Expert Opin Ther Targets·2006
7-preclinical
Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer.
PMID 15685044·Am J Clin Oncol·2005
5-case
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.
PMID 15269140·Clin Cancer Res·2004
3-trial
Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
PMID 12820776·Expert Rev Anticancer Ther·2003
6-review
A 49-year-old male with locally advanced squamous cell carcinoma of the head and neck: the case for sequential chemoradiotherapy.
PMID 16227961·Clin Adv Hematol Oncol·2003
5-case
Palliative chemotherapy in patients with salivary gland neoplasms and preliminary reports of 2 recent phase II studies with trastuzumab and gemcitabine.
PMID 16224411·Clin Adv Hematol Oncol·2003
6-review
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.
PMID 14727246·Semin Oncol·2003
3-trial
Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study.
PMID 12907212·Oral Oncol·2003
3-trial
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer.
PMID 12827298·Cancer Chemother Pharmacol·2003
3-trial
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
PMID 12604730·Oncologist·2003
6-review
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.
PMID 12518365·Cancer·2003
8-other
Perfume fingerprinting by easy ambient sonic-spray ionization mass spectrometry: nearly instantaneous typification and counterfeit detection.
PMID 18946866·Rapid Commun Mass Spectrom·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, DANA FARBER CANCER INSTITUTE
BOSTON, MA 02115 - Phone
- (617) 632-5530
Quick Facts
- NPI
- 1942259098
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile